Amedisys Inc

Amedisys — Q1 2020 Earnings Presentation

20 slides from Amedisys's earnings presentation, May 6, 2020

  1. Slide 1: Amedisys First Quarter 2020 Earnings Call Supplemental Slides

    Amedisys First Quarter 2020 Earnings Call Supplemental Slides May 7th, 2020 Exhibit 99.2

  2. Slide 2: Forward-looking statements

    This presentation may include forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based upon current expectations and assumptions about our business that are subject to a variety of risks and uncertainties that could cau

  3. Slide 3: Q1 2020 Results

    Q1 2020 Results amedisys

  4. Slide 4: Our Key Areas of Focus

    Our Key Areas of Focus Strategic areas of focus and progress made during Q1’20 Home Health*: Total same store admissions +3%. Total same store volume +1% Hospice: Admissions +1%, ADC +4% Personal Care: Billable hours / quarter -10% 1 Organic Growth CMS has determined they will not update the Home He

  5. Slide 5: Highlights and Summary Financial Results (Adjusted): 1Q 2020

    Highlights and Summary Financial Results (Adjusted): 1Q 2020(1) Home Health total same store volume +1%, total same store admissions +3%. Hospice same store admissions +1% Amedisys Consolidated Revenue Growth: +5% EBITDA: $53M (-3%) EBITDA Margin: 11% (-90 bps) EPS: $1.05 (-5%) 1Q’20 Net debt: $216.

  6. Slide 6: Our revenue sources: 1Q'20

    Our revenue sources: 1Q’20 Medicare FFS: Reimbursed over a 30-day period of care Private Episodic: MA and Commercial plans who reimburse us over a 30-day period of care. Generally at rates ~90% – 100% of Medicare Per Visit: Managed care, Medicaid and private payors reimbursing us per visit performed

  7. Slide 7: Home Health and Hospice Segment (Adjusted) – 1Q 2020

    Home Health and Hospice Segment (Adjusted) – 1Q 2020(1) Revenue per Episode down 3.7% Recert rate down 230 bps Y/Y CPV up +$3.47 (+3.9%, raises effective 8/1) Visits per Episode decreased 1.4 Home Health Highlights Same store average daily census (ADC) up 4% Net revenue per day +0.9% ~$0.4M cap expe

  8. Slide 8: General & Administrative Expenses – Adjusted

    General & Administrative Expenses – Adjusted (1,2) Notes: Year over year total G&A as a percentage of revenue increased 170 basis points Home Health segment G&A: 200 bps increase as % of revenue primarily due to raises and the addition of business development resources; 40 bps due to change in staff

  9. Slide 9: Industry Leading Quality Scores

    Industry Leading Quality Scores Note: Top Competitor Avg weighted by CCN count and includes LHC, Kindred, AFAM, EHC and BKD Metric JUL 19 Release OCT 19 Release JAN 20 Release APR 20 PREVIEW Quality of Patient Care 4.27 4.28 4.27 4.26 Entities at 4+ Stars 85% 88% 86% 86% Metric APR 19 Release JUL 19

  10. Slide 10: Hospice Quality: Amedisys Hospice Continues to Move Towards Best-in-Class Hospice Quality

    Hospice Quality: Amedisys Hospice Continues to Move Towards Best-in-Class Hospice Quality

  11. Slide 11: Home Health cost per visit components

    Components 1Q19 4Q’19 1Q’20 YoY Variance Detail Initiatives Salaries $61.54 $64.18 $64.42 $2.88 YoY increase due to planned wage increases and increased costs related to changes to our staffing model partially offset by optimization of discipline mix. Also, YoY increase due to fixed costs (training,

  12. Slide 12: Driving Top Line Growth

    Driving Top Line Growth Continuing growth in all three lines of business Home Health Total Volume Hospice ADC Personal Care Total Hours / Quarter

  13. Slide 13: Debt and Liquidity Metrics

    Debt and Liquidity Metrics ~1.0x net leverage. Proforma for Aseracare, net leverage ~2.1x Net debt defined as total debt outstanding ($394.3M) less cash & restricted cash balance ($177.8M). Leverage ratio (net) is defined as net debt divided by last twelve months adjusted EBITDA ($223.7M). Liquidity

  14. Slide 14: Cash Flow Statement Highlights

    Cash Flow Statement Highlights (1) Free cash flow defined as cash flow from operations less routine capital expenditures and required debt repayments.

  15. Slide 15: Income Statement Adjustments

    Income Statement Adjustments (1) The financial results for the three-month periods ended March 31, 2019, June 30, 2019, September 30, 2019, December 31, 2019 and March 31, 2020 are adjusted for certain items and should be considered a non-GAAP financial measure. A reconciliation of these non-GAAP fi

  16. Slide 16: COVID-19

    COVID-19 6 amedisys

  17. Slide 17: COVID-19: Total Q1'20 Impact

    COVID-19: Total Q1’20 Impact = $3.2M (reported = $4.2M) Impact on volume, rate and gross margin as compared to internal forecast HH & HOSP Total Admits PC Billable Hours Home Health Hospice Actual 2.7% 3.9% Forecast 6.1% 1.2% Impact (3.4%) (2.7%) COVID Impact to Revenue, Cost and Gross Margin Volume

  18. Slide 18: COVID-19 Impact on March and Q1'20

    COVID-19 Impact on March and Q1’20 Home health referrals and admissions hit their low point the week of 4/5 and have begun to recover. Hospice referrals hit their low point week of 3/22 and have begun to recover *Baseline defined as referrals and admits from pre-Covid-19 timeframe of 1/5/20 – 3/14/2

  19. Slide 19: PPE Graphs

    PPE Graphs PPE inventory at care centers – not including centralized PPE supply. We have made significant progress providing our care centers with all critical PPE needed to care for COVID-19 symptomatic and COVID-19 positive patients

  20. Slide 20: COVID-19: Financial Impacts from Recent Regulatory Actions

    COVID-19: Financial Impacts from Recent Regulatory Actions The CARES Act and CMS Waivers provided quantifiable financial impacts to Amedisys; below is a summary of select key provisions Topic Impact Sequestration Holiday Suspension of 2% sequestration from May 1 – Dec. 31, 2020 AMED Impact: ~$21M im

Amedisys — Q1 2020 Earnings Presentation on 6ix